We are pleased to announce the 3rd Protease Inhibitors in Drug Discovery Conference, to be hosted by GTCbio on February 8-9, 2017 in San Diego, CA. Though protease inhibitors hold great therapeutic promise in areas such as inflammation, cardiovascular diseases, and cancer, researchers in the field are still overcoming the challenge of specificity for drug design.
This meeting will provide a forum for scientists from both industry and academia to share recent advances in protease inhibitor research, from biological functions to translational aspects for drug discovery. Speakers will cover topics such as regulation of proteases by exosites, drug design of protease inhibitors, membrane-associated proteolysis, and many more. In addition to cutting-edge scientific presentations, attendees will be able to form new connections during dedicated networking sessions.
We hope to see you there!